Breaking News

SCG Cell Therapy Opens Cell Therapy Manufacturing Facility in Singapore

Will increase local production capacity while significantly reducing the cost of cell therapy.

SCG Cell Therapy Pte Ltd (SCG), a biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, opened a cell therapy cGMP manufacturing facility and R&D Centre in Singapore. With the support of the Singapore Economic Development Board (EDB), the new facility leverages and extends SCG’s capabilities in advanced cell therapy manufacturing and off-the-shelf human-induced Pluripotent Stem Cell (iPSC) technology. The facility will supply cell ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters